Navigation Links
COX-2 inhibitors Lessen Breast Cancer Risk

Selective usage of COX-2 inhibitors like rofecoxib (Vioxx) and celecoxib (Celebrex) reduces breast cancer risk by 71%, according to a study. The Ohio State University College of Medicine and Public Health's Randall Harris led the // research which came to this conclusion. The nonsteroidal anti-inflammatory drugs (NSAIDs) play a prominent role in the prevention of breast cancer.

The researchers observed that while daily use of selective COX-2 inhibitors was associated with a 71% reduction in the risk of breast cancer, non-selective COX-2 inhibitors, such as aspirin and ibuprofen, also reduced the risk of breast cancer. The study's results show that selective COX-2 inhibitors, as a group, were associated with a significantly reduced risk of breast cancer when taken daily for at least two years.

While a daily dose of 200 mg celecoxib reduced the risk of breast cancer by 83%, a daily dose of 25 mg rofecoxib reduced the risk of breast cancer by 64%. Regular use of non-selective COX-2 inhibitors like aspirin (325 mg), ibuprofen (200mg) and naproxen (250 mg) also significantly reduced the risk of breast cancer, but less so than the regular intake of selective COX-2 inhibitors. It was found that Ibuprofen and aspirin significantly decreased the risk of developing breast cancer when taken at least every other day for at least five years.

However, the researchers also found that regular intake of acetaminophen, an analgesic lacking COX-2 activity, had no effect on the risk of breast cancer. The study is published in the open access journal BMC Cancer.

Edited (ANI)
'"/>




Page: 1

Related medicine news :

1. Green Tea and COX-2 Inhibitors Combine to Slow Growth of Prostate Cancer
2. Phase 3 trials of two multi-kinase inhibitors against cancer
3. Lessening operation and recovery time
4. Physical Exertion Can Lessen Depression
5. Risk Of Stroke Can Be Lessened By Proper Diet
6. Fatigue After Liver Transplantation Does Not Lessen With Time
7. Vulnerability to Ear Infections Lessened by Breast Feeding
8. A Discovery That may Lessen a Health Disparity
9. Consensus on "Combination Therapy" for Breast Cancer
10. Breast cancer treatment to be determined by gene test
11. Breast Feeding prevents obesity later on in life

Post Your Comments:
(Date:11/9/2009)...on could boost self-esteem, researchers say , ...c children are more likely to have handwriting pro...se without autism, researchers say. , The new s...he study participants had autism spectrum disorder... range for perceptual reasoning on an IQ test. ,...
(Date:11/9/2009)...regained sexual function, study says, , ...s were able to restore sexual function to rabbits ...in the lab and implanting it, a new study reports....searchers say the technique could one day be used ..."We were able to show the tissue was able to integ...
(Date:11/9/2009)...Newswire-FirstCall/ - Hard To Treat Diseases (HTDS...ovartis, a US$41 billion international healthcare ...accine partner, Zhejiang Tianyuan Bio-Pharmaceutic...zerland will begin a five-year, $1 billion China i...ally increase its investment in its China R&D ...
(Date:11/9/2009)...w may be too late when it comes to preventing or i...lub, Inc. (Take Off Pounds Sensibly), the nonprofi... (Vocus) November 9, 2009 -- Tomorrow ...roving a diabetes condition, according to TOPS Clu...weight-loss support organization., , ,Diabetes is ...
(Date:11/9/2009)...dy highlights positive influence of sports partici...osemont, IL (Vocus) November 9, 2009 -- As people ...Recent research has highlighted the importance of ...hese issues. However, a new study published in the...idisciplinary Approach reveals that there may be ...
Breaking Medicine News(10 mins):Health News:Handwriting Skills May Lag in Kids With Autism 2Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2
...patients informed about being paid to enrol them i... phase 4 clinical trials - are a signicnificant pa...s a new drug// and the family doctor reporting any...ortant way of revealing uncommon side effects. ...
...researchers have found that bone loss can be treme...t for kidney stones has the spin-off of increasing... a treatment// for kidney stones. Hence it has bee... a period ranging from 10 to 110 months to prevent...
...are protective substances, produced by the body in...ill the TB bacteria, researchers in the UK report....urnal Nature Medicine,// these heat-shock proteins...aham R. Stewart, of Imperial College of Science Te...
...merican women who are health have increased risk o...research on risk factors for heart disease and str...ia University report on how cholesterol and other ...5 years. The women were followed up for several ye...
... recent study shows that a leaky heart valve raise...brillation (AF) the upper chambers of the heart be...inked to heart attack and stroke.// Researchers at...flows backwards into the upper chamber in people w...
...ew bandages developed by US researchers take an ac...ice show that hydrogel bandages speed up healing.T...and six times and become pliable when wet.// Unlik... The researchers believe that the bandages will...
Other Medicine News:
(Date:11/9/2009)...9, 2009 Monsanto Company...announced that they have entered into an agreement...lage Research Center located in Chesterfield, Mo. ...cquire the property from Pfizer for $435 million t...ave operations at Chesterfield Village through a l...
(Date:11/9/2009)...Va., Nov. 9 LifeNet Health, a lead...aunch of Vertigraft Cervical Bio-Implant (VG2C) wi...; is a new, proprietary glycerol-based preservatio...e stored in a fully hydrated state at ambient temp...eze-dry bio-implants, doing away with lengthy thaw...
(Date:11/9/2009)..., Nov. 9 Thomson Reuters today a...CareFocus, a leading clinical surveillance solutio...nts in real-time and respond immediately to improv...ent. ,, This upgrade is available to current Ca...areFocus 2.0 contains several powerful enhancement...
Breaking Medicine Technology:Monsanto to Purchase Chesterfield Village Research Center From Pfizer 2Monsanto to Purchase Chesterfield Village Research Center From Pfizer 3LifeNet Health Announces First Bio-Implant with New Preservation Technology 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Blood flow in Alzheimers disease 52791 1Blood flow in Alzheimers disease 52791 2Nanophysics 3A Serving up Buckyballs on a silver platter 9367 1Scientists track impact of DNA damage in the developing brain 9364 1Scientists track impact of DNA damage in the developing brain 9364 2Scientists track impact of DNA damage in the developing brain 9364 3
...n spreads faster than it takes to diagnose it in t...e University have developed a test to bring,that t...assistant professor, and Greg Peterson, research,m...c medicine and,pathobiology, use a device called a...enetic markers that set one pathogen apart from an...
... NVAX ) today announced that the Company will hold...om the Phase I/IIa human clinical,trial of Novavax...t 11:00,a.m. Eastern Time on August 26, 2008., Th...ef Executive,Officer Dr. Rahul Singhvi and other m...al Officer, Dr. Penny Heaton. A question and answe...
Other Medicine Technology:Rapid Test for Pathogens Developed By K-State Researchers Could Be Used to Detect Diseases Used By Bioterrorists 2Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008 2
Agarose,separation < 500 bp
...on of agar. Forms gel with superior mechanical qua...on microscope slides or transparent plastic. When ...le or no deterioration on staining with either pro...lling temperature: 42°C. Soluble in Hot H 2 O....
...s and instruments designed to perform the main tes... blood transfusion centers. The system is based ad... or the analysis of digitized images. The quality ...bulin reagents used gives the system an excellent ...
...0 Automated Microplate System, the PK CMV-PA Syste...for the detection of cytomegalovirus. Relative sen...red to EIA measures 99.8% and 99.3% respectively. ...des excellent lot-to-lot consistency and eliminate...
Medicine Products: